These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31641353)

  • 21. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Zhang X; Huang G; Ye J; Xu M; Cong L; He X; Huang T; Kuang M; Xie X
    Ultrasound Med Biol; 2019 Aug; 45(8):1933-1943. PubMed ID: 31109841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma.
    Tomonari A; Tsuji K; Yamazaki H; Aoki H; Kang JH; Kodama Y; Sakurai Y; Maguchi H
    Hepatol Res; 2013 Jul; 43(7):728-34. PubMed ID: 23198863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel software platform for volumetric assessment of ablation completeness.
    Solbiati M; Muglia R; Goldberg SN; Ierace T; Rotilio A; Passera KM; Marre I; Solbiati L
    Int J Hyperthermia; 2019; 36(1):337-343. PubMed ID: 30729818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
    Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
    Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Ablative Margin After Microwave Ablation for Hepatocellular Carcinoma Using Deep Learning-Based Deformable Image Registration.
    An C; Jiang Y; Huang Z; Gu Y; Zhang T; Ma L; Huang J
    Front Oncol; 2020; 10():573316. PubMed ID: 33102233
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
    Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
    World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
    Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.
    Tokunaga S; Koda M; Matono T; Sugihara T; Nagahara T; Ueki M; Murawaki Y; Kakite S; Yamashita E
    Br J Radiol; 2012 Jun; 85(1014):745-52. PubMed ID: 21385915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
    Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
    Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
    Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
    Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.
    Han S; Lee JM; Lee DH; Yoon JH; Chang W
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1579-1596. PubMed ID: 34312690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization.
    Koh YH; Choi JI; Kim HB; Kim MJ
    Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
    Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
    J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma.
    Motoyama T; Ogasawara S; Chiba T; Higashide T; Yokota H; Kanogawa N; Suzuki E; Ooka Y; Tawada A; Irie R; Ochi S; Masuda Y; Uno T; Yokosuka O
    Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
    Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
    J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablation margin assessment of liver tumors with intravenous contrast-enhanced C-arm computed tomography.
    Iwazawa J; Ohue S; Hashimoto N; Mitani T
    World J Radiol; 2012 Mar; 4(3):109-14. PubMed ID: 22468192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis.
    Frich L; Hagen G; Brabrand K; Edwin B; Mathisen O; Aaløkken TM; Gladhaug IP
    J Vasc Interv Radiol; 2007 Sep; 18(9):1134-40. PubMed ID: 17804776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.